How many insider trades does FilingIQ track for CELC?

FilingIQ tracks 130 Form 4 insider transactions for CELC (Celcuity Inc.), covering filings from Sep 19, 2017 onwards. 14 of those were filed in the last 90 days.

Are CELC insiders net buyers or net sellers?

Across the full Form 4 history for CELC, 14 transactions (11%) were open-market purchases and 55 (42%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CELC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CELC in?

Celcuity Inc. (CELC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.90B.

CELC insider trading

NasdaqCM Healthcare

Celcuity Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

130

Last 90 days

Buys / sells

11% / 42%

Market cap

$4.90B

About Celcuity Inc.

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). It also engages in developing of CELsignia diagnostic platform. The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is based in Minneapolis, Minnesota.

Company website: www.celcuity.com

CELC insider activity at a glance

FilingIQ has scored 130 insider transactions for CELC since Sep 19, 2017. The most recent filing in our index is dated May 4, 2026.

Across the full history, 14 open-market purchases and 55 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CELC insider trades is 52.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CELC trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding CELC

Avoro Capital Advisors LLC

$310.30M · 3.0% of AUM

VR Adviser, LLC

$29.50M · 5.0% of AUM

Frequently asked

How many insider trades does FilingIQ track for CELC?: FilingIQ tracks 130 Form 4 insider transactions for CELC (Celcuity Inc.), covering filings from Sep 19, 2017 onwards. 14 of those were filed in the last 90 days.
Are CELC insiders net buyers or net sellers?: Across the full Form 4 history for CELC, 14 transactions (11%) were open-market purchases and 55 (42%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CELC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CELC in?: Celcuity Inc. (CELC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.90B.

Methodology & sources

Every CELC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.